 | | PRD_000556 | | Name: | AERUGINOSIN 98-B | | Formula: | C29 H46 N6 O9 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000562 | | Name: | (4R)-N-tert-butyl-3-[(2S,3S)-2-hydroxy-3-({N-[(isoquinolin-5-yloxy)acetyl]-S-methyl-L-cysteinyl}amino)-4-phenylbutanoyl]-1,3-thiazolidine-4-carboxamide | | Formula: | C33 H41 N5 O6 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000585 | | Name: | (4R)-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-3-[(2S,3S)-2-hydroxy-3-({N-[(isoquinolin-5-yloxy)acetyl]-S-methyl-
L-cysteinyl}amino)-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide | | Formula: | C40 H45 N5 O7 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000705 | | Name: | MICROGININ FR1 | | Formula: | C38 H57 N5 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000723 | | Name: | PYOVERDIN C-E Fe Complex | | Formula: | C55 H82 Fe N17 O22 | | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000724 | | Name: | PYOVERDIN 18-1 Fe Complex | | Formula: | C57 H84 Fe N17 O24 | | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000725 | | Name: | PYOVERDIN R Fe Complex | | Formula: | C48 H64 Fe N15 O21 | | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000726 | | Name: | PYOVERDIN 13525 Fe Complex | | Formula: | C49 H71 Fe N14 O19 | | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000728 | | Name: | Synthetic PYOVERDINE Fe Complex | | Formula: | C56 H81 Fe N17 O24 | | Description: | IN IRON-DEFICIENT CONDITIONS, PSEUDOMONAS
AERUGINOSA SECRETES A MAJOR FLUORESCENT
SIDEROPHORE NAMED PYOVERDIN (PVD),
WHICH AFTER CHELATING IRON(III) IS TRANSPORTED
BACK INTO THE CELL VIA ITS OUTER MEMBRANE RECEPTOR
FPVA. FPVA IS A TONB-DEPENDENT TRANSPORT PROTEIN
AND HAS THE ABILITY TO BIND PVD IN ITS APO-
OR IRON-LOADED FORM. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000759 | | Name: | THIOPEPTIDE THIOSTREPTON WITH EPIMER FORM OF RESIDUE 9 | | Formula: | C69 H81 N18 O17 S5 | | Description: | THIOSTREPTON IS A HETEROCYCLIC THIOPEPTIDE,
CONSISTING OF FOUR THIAZOLES ONE THIOZOLINE
ONE PIPERIDEINE RINGS.
A MODIFIED QUINOLINE, RESIDUE 0, IS LINKED TO
MAIN-CHAIN RESIDUE 1 AND SIDE-CHAIN OF RESIDUE 12.
IN THIS ENTRY RESIDUE 9 WAS CHEMICALLY MODIFIED
FROM D-CYS TO L-CYS AND RESIDUE 17 (HET DHA)
WAS DELETED. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_002512 | | Name: | all-D Helicon Polypeptide FP40914 | | Formula: | C92 H114 N20 O22 S2 | | Definition date: | 2023-02-15 | | Last modified: | 2023-02-15 |
|
 | | PRD_002513 | | Name: | all-D Helicon Polypeptide FP40926 | | Formula: | C86 H116 N22 O24 S3 | | Definition date: | 2023-02-15 | | Last modified: | 2023-02-15 |
|
 | | PRD_002514 | | Name: | an all-D Helicon Polypeptide FP40927 | | Formula: | C81 H122 N19 O21 S2 | | Definition date: | 2023-02-15 | | Last modified: | 2023-02-15 |
|
 | | PRD_002515 | | Name: | all-D Helicon Polypeptide FP40918 | | Formula: | C84 H115 N22 O26 S2 | | Definition date: | 2023-02-15 | | Last modified: | 2023-02-15 |
|
 | | PRD_002097 | | Name: | [[[(4S)-5-[[(2S)-1-[[(2S)-5-[[azaniumylidene(azanyl)methyl]amino]-1-oxidanylidene-pentan-2-yl]amino]-3-methyl-1-oxidanylidene-butan-2-yl]amino]-5-oxidanylidene-4-[[(2S)-1-oxidanyl-1-oxidanylidene-3-phenyl-propan-2-yl]carbamoylamino]pentyl]amino]-azanyl-methylidene]azanium | | Formula: | C27 H46 N10 O6 | | Description: | Acts as a reversible inhibitor of serine/cysteine proteases and some trypsin-like serine proteases. | | Definition date: | 2013-08-07 | | Last modified: | 2022-10-20 |
|
 | | PRD_002491 | | Name: | Sa-D2 | | Formula: | C88 H122 N19 O23 S2 | | Definition date: | 2022-08-10 | | Last modified: | 2022-08-10 |
|
 | | PRD_002454 | | Name: | Substrate-like cysteine protease inhibitor | | Formula: | C46 H70 Cl N10 O9 | | Definition date: | 2021-09-01 | | Last modified: | 2021-09-01 |
|
 | | PRD_002385 | | Name: | Papain-like protease peptide inhibitor VIR250 | | Formula: | C23 H32 N6 O6 S | | Definition date: | 2020-05-20 | | Last modified: | 2020-05-20 |
|
 | | PRD_001086 | | Name: | Microviridin J | | Formula: | C80 H108 N19 O22 | | Definition date: | 2014-04-02 | | Last modified: | 2014-04-02 |
|
 | | PRD_001219 | | Name: | Lantibiotic 107891 | | Formula: | C94 H127 Cl N26 O26 S5 | | Description: | NAI-107 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND SER INTO DEHYDRATED AA AND THE FORMATION OF THIOETHER BONDS WITH CYSTEINE. THE CARBOXY-TERMINAL BETA-METHYLLANTHIONINE UNDERGOES DECARBOXYLATION. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE MODIFIED PRECURSOR. | | Definition date: | 2014-03-05 | | Last modified: | 2014-03-05 |
|
 | | PRD_001055 | | Name: | (4R)-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-3-[(2S,3S)-2-hydroxy-3-{[S-methyl-N-(phenylacetyl)-L-cysteinyl]ami
no}-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide | | Formula: | C37 H44 N4 O6 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2013-08-26 |
|
 | | PRD_001070 | | Name: | bacitracin A2 | | Formula: | C66 H106 N17 O16 S | | Definition date: | 2013-08-14 | | Last modified: | 2013-08-14 |
|
 | | PRD_000970 | | Name: | Synthetic peptide LR | | Formula: | C43 H72 N13 O13 S | | Definition date: | 2013-07-24 | | Last modified: | 2013-07-24 |
|
 | | PRD_000921 | | Name: | Noxa BH3 peptide (cysteine-mediated cross-linked) | | Formula: | C106 H179 N33 O25 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_001092 | | Name: | D-phenylalanyl-L-prolyl-N~5~-[amino(iminio)methyl]-D-ornithyl-L-cysteinamide | | Formula: | C23 H37 N8 O4 S | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
